Elder Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.95 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 253.09%
(FY 2023)
- Ebitda -458.88%
(FY 2023)
- Net Worth 0.15%
(FY 2023)
- Total Assets 541.94%
(FY 2023)
About Elder Laboratories
The Corporate was formerly known as Lyka Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹10.95 Cr.
Rubi Mukhopadhyay, Biswajit Pan, and Anand Parmanandka serve as directors at the Company.
- CIN/LLPIN
U24309WB2021PLC245140
- Company No.
245140
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 May 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Elder Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rubi Mukhopadhyay  | Director | 13-May-2021 | Current |
| Biswajit Pan | Director | 13-May-2021 | Current |
| Anand Parmanandka | Director | 13-May-2021 | Current |
Financial Performance of Elder Laboratories.
Elder Laboratories Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 253.09% increase in profit. The company's net worth moved up by a moderate rise of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elder Laboratories?
In 2022, Elder Laboratories had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alventa Pharma LimitedActive 8 years 2 monthsRubi Mukhopadhyay, Biswajit Pan and 1 more are mutual person
- Aleris Pharmaceuticals LimitedActive 3 years 7 months
Rubi Mukhopadhyay, Biswajit Pan and 1 more are mutual person
- Nicholas Pharma India LimitedActive 3 years 9 months
Rubi Mukhopadhyay, Biswajit Pan and 1 more are mutual person
- Allenburys Pharma LimitedActive 4 years 2 months
Rubi Mukhopadhyay, Biswajit Pan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jun 2024 | ₹9.52 M | Open |
Indian Bank Creation Date: 22 Dec 2023 | ₹10.00 Cr | Open |
How Many Employees Work at Elder Laboratories?
Unlock and access historical data on people associated with Elder Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elder Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elder Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
